Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11700-11712
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11700
Table 3 Morbidity, peri-operative mortality, and length of stay associated cytoreduction with hyperthermic intraperitoneal chemotherapy
Ref.YearSample No.Complication ratePeri-operative mortalityRe-operationAbdominalCardiac/pulmonarySepsisWound InfectionOther infectionRenalVascularHematologicOtherLOS
Park et al[33]19991824%1111211
Feldman et al[48]20034925%024523112
Costamagna et al[61]20032426%11
Brigand et al[6]20061540%0000016.3
Elias et al[60]20072654%441141322281
Gomez et al[113]2007771%41.51
Hesdorffer et al[55]20082730%021113
Passot et al[114]20082247%0
Chua et al[115]20092065%125211316.51
Yano et al[62]20091741%5.82213
Kluger et al[54]20104734%2139229211161
Cao et al[46]201229433%250382615231
Alexander et al[47]201321130%2.32020259681111
Wong et al[52]20132965%4141621049
Deraco et al[37]20031925%03113321
Deraco et al[39]20032814%0
Deraco et al[38]20036123%07
Deraco et al[40]20064915%G39245435241
Deraco et al[50]201311641%G32.625
Baratti et al[36]2007128%G3011
Baratti et al[116]2008520%G3011
Baratti et al[35]20108328%G32.4
Baratti et al[117]2010128%G3018
Baratti et al[53]20126028%G30784317251
Baratti et al[34]201310839%1.914106107
Yan et al[45]200610036%G35687115810221
Yan [44]20077041%G3343432453231
Yan et al[42]200940146%G3274573925221